These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10743597)
41. [Experiences in the conservative treatment of cholecystopathies and cholangiopathies]. Baumgart R Z Allgemeinmed; 1969 Jul; 45(19):926-7. PubMed ID: 5800266 [No Abstract] [Full Text] [Related]
42. [Experiences in the treatment of bacterial diseases with methacycline]. Stagelschmidt P; Fischer W Med Welt; 1968 Feb; 9():457-60. PubMed ID: 5713316 [No Abstract] [Full Text] [Related]
43. Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics. Eggimann P; Jamdar S; Siriwardena AK Crit Care; 2006; 10(5):229. PubMed ID: 16959048 [TBL] [Abstract][Full Text] [Related]
45. [Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]. Jansen JB Ned Tijdschr Geneeskd; 2002 Mar; 146(11):535. PubMed ID: 11925811 [No Abstract] [Full Text] [Related]
46. [Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]]. van der Voort PH; van Roon EN; Egbers PH; Gerritsen RT; Kuiper MA Ned Tijdschr Geneeskd; 2002 Mar; 146(11):535-6. PubMed ID: 11925812 [No Abstract] [Full Text] [Related]
47. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]. Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012 [TBL] [Abstract][Full Text] [Related]
48. New developments and concepts in antimicrobial therapy for intra-abdominal infections. Younes Z; Johnson DA Curr Gastroenterol Rep; 2000 Aug; 2(4):277-82. PubMed ID: 10981024 [TBL] [Abstract][Full Text] [Related]
49. [Problems in the etiology, pathogenesis and treatment of chronic inflammatory diseases of the biliary system]. Iepishyn AV; Sherstiuk PIa; Khabarova NA; Pinchuk AK Lik Sprava; 1998; (5):11-9. PubMed ID: 9793297 [No Abstract] [Full Text] [Related]
50. [Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]. Schippers EF; van Dissel JT Ned Tijdschr Geneeskd; 2002 Mar; 146(11):536-7; author reply 537. PubMed ID: 11925813 [No Abstract] [Full Text] [Related]
51. Cefazolin in the treatment of biliary tract infections. Paulet P Acta Gastroenterol Belg; 1976; 39(7-8):293-7. PubMed ID: 1015201 [No Abstract] [Full Text] [Related]
52. [12 years of ambulant treatment with Hepaticum-Medice]. Grebe H Dtsch Med J; 1966 Apr; 17(7):202-4. PubMed ID: 5929222 [No Abstract] [Full Text] [Related]
53. Dissecting the effect of moxifloxacin in mice with infected necrosis in taurocholate induced necrotizing pancreatitis. Seifert GJ; Poxleitner PJ; Richter SC; Hopt UT; Wittel UA Pancreatology; 2014; 14(3):179-85. PubMed ID: 24854613 [TBL] [Abstract][Full Text] [Related]
55. [Observations on the use of rifampicin in infections of the biliary tract. Preliminary note]. Marigo S; Maoli E Arch Maragliano Patol Clin; 1969; 25(5):355-8. PubMed ID: 5395552 [No Abstract] [Full Text] [Related]
58. [Mepenam application for prophylaxis and treatment of purulent complications of an acute destructive pancreatitis]. Nychytaĭlo MIu; Bulyk II Klin Khir; 2011 Dec; (12):22-4. PubMed ID: 22432188 [TBL] [Abstract][Full Text] [Related]
59. [Enteral oxygen therapy in the treatment of chronic diseases of the liver and biliary ducts]. Nezhdanova OV; Vashchenko MA Vrach Delo; 1968 Jan; 1():120-1. PubMed ID: 5672340 [No Abstract] [Full Text] [Related]